terfenadine has been researched along with Leukemia, Basophilic, Acute in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passante, E | 1 |
| Ehrhardt, C | 1 |
| Sheridan, H | 1 |
| Frankish, N | 1 |
1 other study available for terfenadine and Leukemia, Basophilic, Acute
| Article | Year |
|---|---|
In vitro inhibition of rat basophilic leukaemia mast cell (RBL-2H3) degranulation by novel indane compounds.
Topics: Animals; Antioxidants; beta-N-Acetylhexosaminidases; Cell Degranulation; Cell Line; Dose-Response Re | 2008 |